We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are u... Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder caused by mutations in the X-linked gene, methyl-CpG-binding protein 2. Show more
Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL) PR Newswire NEW YORK, April 19, 2024 NEW YORK, April 19, 2024 /PRNewswire/...
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL PR Newswire NEW YORK, April 16, 2024 NEW YORK, April 16, 2024...
Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm PR Newswire NEW YORK, April 12, 2024 NEW YORK, April 12, 2024...
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated...
Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm PR Newswire NEW YORK, April 9, 2024 NEW YORK, April 9, 2024...
Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024...
Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL PR Newswire NEW YORK, April 2, 2024 NEW YORK, April 2...
Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm PR Newswire NEW YORK, March 29, 2024 NEW YORK, March 29, 2024...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.41 | -10.0244498778 | 4.09 | 4.2005 | 3.6 | 1525411 | 3.87036766 | CS |
4 | -0.98 | -21.0300429185 | 4.66 | 5.2 | 3.6 | 1207320 | 4.33420011 | CS |
12 | -2.99 | -44.8275862069 | 6.67 | 6.67 | 3.6 | 1306136 | 5.00014672 | CS |
26 | -1.49 | -28.8201160542 | 5.17 | 10.45 | 3.6 | 1358732 | 6.09591457 | CS |
52 | -4.33 | -54.0574282147 | 8.01 | 10.45 | 3.6 | 1119704 | 6.87951258 | CS |
156 | -8.26 | -69.1792294807 | 11.94 | 31.5 | 3.6 | 1269351 | 12.20415804 | CS |
260 | 0.88 | 31.4285714286 | 2.8 | 31.5 | 2.2 | 1236097 | 10.62891899 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions